[HTML] nih.gov

[HTML][HTML] Clinical significance of loss of heterozygosity for M6P/IGF2R in patients with primary hepatocellular carcinoma

HS Jang, KM Kang, BO Choi, GY Chai… - World journal of …, 2008 - ncbi.nlm.nih.gov
AIM: To investigate the relationship between loss of heterozygosity (LOH) for mannose 6-
phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) and the outcomes for primary …
被引用次数：32 相关文章

Clinical significance of loss of heterozygosity for M6P/IGF2R in patients with primary hepatocellular carcinoma.

HS Jang, KM Kang, BO Choi, GY Chai… - World Journal of …, 2008 - europepmc.org
Aim To investigate the relationship between loss of heterozygosity (LOH) for mannose 6-
phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) and the outcomes for primary …

Clinical significance of loss of heterozygosity for M6P/IGF2R in patients with primary hepatocellular carcinoma

HS Jang, KM Kang, BO Choi… - World journal of …, 2008 - pubmed.ncbi.nlm.nih.gov
Aim To investigate the relationship between loss of heterozygosity (LOH) for mannose 6-
phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) and the outcomes for primary …
[PDF] psu.edu

[PDF][PDF] Clinical significance of loss of heterozygosity for M6P/IGF2R in patients with primary hepatocellular carcinoma

HS Jang, KM Kang, BO Choi, GY Chai, SC Hong… - World J …, 2008 - Citeseer
AIM: To investigate the relationship between loss of heterozygosity (LOH) for mannose 6-
phosphate/insulinlike growth factor 2 receptor (M6P/IGF2R) and the outcomes for primary …
[PDF] researchgate.net

[PDF][PDF] Clinical significance of loss of heterozygosity for M6P/IGF2R in patients with primary hepatocellular carcinoma

HS Jang, KM Kang, BO Choi, GY Chai… - World J …, 2008 - researchgate.net
AIM: To investigate the relationship between loss of heterozygosity (LOH) for mannose 6-
phosphate/insulinlike growth factor 2 receptor (M6P/IGF2R) and the outcomes for primary …
[HTML] wjgnet.com

[HTML][HTML] Clinical significance of loss of heterozygosity for M6P/IGF2R in patients with primary hepatocellular carcinoma

HS Jang, KM Kang, BO Choi, GY Chai… - World Journal of …, 2008 - wjgnet.com
AIM: To investigate the relationship between loss of heterozygosity (LOH) for mannose 6-
phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) and the outcomes for primary …

[引用][C] Clinical significance of loss of heterozygosity for M6P/IGF2R in patients with primary hepatocellular carcinoma

J HS - World J Gastroenterol, 2008 - cir.nii.ac.jp

Clinical significance of loss of heterozygosity for M6P/IGF2R in patients with primary hepatocellular carcinoma

HS Jang, KM Kang, BO Choi, GY Chai… - World Journal of …, 2008 - cuk.elsevierpure.com
Aim: To investigate the relationship between loss of heterozygosity (LOH) for mannose 6-
phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) and the outcomes for primary …

Clinical significance of loss of heterozygosity for M6P/IGF2R in patients with primary hepatocellular carcinoma

HS Jang, KM Kang, BO Choi, GY Chai, SC Hong… - 2008 - scholarworks.gnu.ac.kr
AIM: To investigate the relationship between loss of heterozygosity (LOH) for mannose 6-
phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) and the outcomes for primary …

Clinical significance of loss of heterozygosity for M6P/IGF2R in patients with primary hepatocellular carcinoma.

HS Jang, KM Kang, BO Choi, GY Chai… - World Journal of …, 2008 - europepmc.org
Aim To investigate the relationship between loss of heterozygosity (LOH) for mannose 6-
phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) and the outcomes for primary …